A look at FNF technical analysis shows that its 14-day Relative Strength Index (RSI) is in a neutral zone after reaching 67.85 point. Its trading volume has lost -133950 shares compared to readings over the past three months as it recently exchanged 1246050 shares. This means there is reduced activity from short-term traders as per session, its average trading volume is 1380000 shares, and this is 0.9 times the normal volume.
Fidelity National Financial, Inc. (NYSE:FNF) dipped by -1.03% over the past three months which led to its overall six-month decrease to stand at -11.91%. The equity price rose 1.11% this week, a trend that has led to both investors and traders taking note of the stock. A look at its monthly performance shows that its shares have recorded a 13.77% gain over the past 30 days. Over the past 12 months the stock has embarked on a drop that has seen it decline -17% and is now up by 9.83% since start of this year.
Experts from research firms are bullish about the near-term performance of Fidelity National Financial, Inc. (FNF) with most of them predicting a $42.8 price target on a short-term (12 months) basis. The average price target by the analysts will see a 23.95% rise in the stock and would lead to FNF’s market cap to surge to $11.67B. The stock has been rated an average 0, which roughly stands towards the bullish end of the spectrum. Reuters looked into the 6 analysts that track Fidelity National Financial, Inc. (NYSE:FNF) and find out that 1 of them rated it as a Hold. 5 of the 5 analysts rated it as a Buy or a Strong Buy while 0 advised investors to desist from buying the stock or sell it if they already possess it.
The price of Cigna Corporation (NYSE:CI) currently stands at $196.92 after it went up by $3.84 or 1.99% and has found a strong support at $194.68 a share. If the CI price drops below that critical support, then it would lead to a bearish trend. In the short-term, a dip below the $192.43 mark would also be bad for the stock as it means that the stock would plunge by 2.28% from its current position. However, if the stock price is able to trade above the resistance point around $198.44, then it could likely surge higher to try and break the upward resistance which stands at $199.95 a share. Its average daily volatility over the past one month stands at 2.71%. The stock has plunged by 1.51% from its 52-weeks high of $193.95 which it reached on Jan. 29, 2018. In general, it is 17.22% above its 52-weeks lowest point which stands at $163.02 and this setback was observed on Mar. 13, 2018.
Analysts have predicted a price target for Cigna Corporation (CI) for 1 year and it stands at an average $239.52/share. This means that it would likely increase by 21.63% from its current position. The current price of the stock has been moving between $193.95 and $197.71. Some brokerage firms have a lower target for the stock than the average, with one of them setting a price target as low as $160. On the other hand, one analyst is super bullish about the price, setting a target as high as $304.
The CI stock Stochastic Oscillator (%D) is at 69.97%, which means that it is currently neutral. The shares P/S ratio stands at 1.67 which compares to the 1.04 recorded by the industry or the 21.76 by the wider sector. The stock currently has an estimated price-earnings (P/E) multiple of 11.75, which is lower than the 16.22 multiple of 12-month price-earnings (P/E). The company’s earnings have gone up, with a quarterly increase rate of 11.5% over the past five years.
Analysts view Cigna Corporation (NYSE:CI) as a Buy, with 1.9 consensus rating. Reuters surveyed 21 analysts that follow CI and found that 4 of those analysts rated the stock as a Hold. The remaining 17 were divided, with 17 analyst rating it as a Buy or a Strong Buy while 0 analysts advised investors to desist from buying Cigna Corporation (CI) shares or sell it if they already own it.